VYGR - Voyager Therapeutics, Inc.

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 8.57

Open

$ 8.87

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 8.52 - $ 8.87

52 Week Range

$ 6.06 - $ 14.34

Volume

387,526

Average Volume

Market Cap

381.96M

Beta (5Y Monthly)

$ 1.29

PE Ratio (TTM)

$ 2.89

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-28-2024	12-31-2023	10-K
2	11-06-2023	09-30-2023	10-Q
3	08-03-2023	06-30-2023	10-Q
4	05-09-2023	03-31-2023	10-Q
5	03-07-2023	12-31-2022	10-K
6	11-08-2022	09-30-2022	10-Q
7	08-04-2022	06-30-2022	10-Q
8	05-04-2022	03-31-2022	10-Q
9	03-08-2022	12-31-2021	10-K
10	11-02-2021	09-30-2021	10-Q
11	08-09-2021	06-30-2021	10-Q
12	05-10-2021	03-31-2021	10-Q
13	02-25-2021	12-31-2020	10-K
14	11-09-2020	09-30-2020	10-Q
15	08-10-2020	06-30-2020	10-Q
16	05-06-2020	03-31-2020	10-Q
17	03-03-2020	12-31-2019	10-K
18	11-06-2019	09-30-2019	10-Q
19	08-09-2019	06-30-2019	10-Q
20	05-07-2019	03-31-2019	10-Q
21	02-26-2019	12-31-2018	10-K
22	11-07-2018	09-30-2018	10-Q
23	08-07-2018	06-30-2018	10-Q
24	05-10-2018	03-31-2018	10-Q
25	03-14-2018	12-31-2017	10-K
26	11-02-2017	09-30-2017	10-Q
27	08-08-2017	06-30-2017	10-Q
28	05-09-2017	03-31-2017	10-Q
29	03-15-2017	12-31-2016	10-K
30	11-10-2016	09-30-2016	10-Q
31	08-11-2016	06-30-2016	10-Q
32	05-12-2016	03-31-2016	10-Q
33	03-17-2016	12-31-2015	10-K
34	12-17-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Voyager Therapeutics Presents Data for Sec...
05/08/2024 10:12:34

Translational potential of TRACER-derived AAV capsids demonstrated by data across multiple species (murine, porcine, multiple...

Voyager Therapeutics To Present Translatio...
04/22/2024 20:31:45

Selection Of The Development Candidate Tri...
04/16/2024 11:12:24

Voyager Therapeutics And Neurocrine Biosci...
04/16/2024 11:07:51

Voyager Therapeutics And Neurocrine Biosci...
04/16/2024 11:06:21

Voyager Therapeutics Said Co And CFO Peter...
04/02/2024 20:36:35

-8-K

Guggenheim Initiates Coverage On Voyager T...
03/26/2024 10:39:06

Guggenheim analyst Debjit Chattopadhyay initiates coverage on Voyager Therapeutics (NASDAQ:VYGR) with a Buy rating and annou...

analyst-bullish-on-gene-therapy-focused-voyager-therapeutics-sees-best-in-class-potential-for-its-neurogenetic-medicine-platform

Analyst Bullish On Gene Therapy-Focused Vo...
03/19/2024 18:16:11

Unlock potential with Voyager Therapeutics as HC Wainwright initiates coverage highlights its TRACER capsid platform, promising...

HC Wainwright & Co. Initiates Coverage On ...
03/19/2024 10:50:17

HC Wainwright & Co. analyst Patrick Trucchio initiates coverage on Voyager Therapeutics (NASDAQ:VYGR) with a Buy rating ...

Citigroup Initiates Coverage On Voyager Th...
03/07/2024 08:49:59

Citigroup analyst David Hoang initiates coverage on Voyager Therapeutics (NASDAQ:VYGR) with a Buy rating and announces Price...

tech-stocks-set-to-rise-thursday-as-january-inflation-data-fails-to-scare-markets-small-caps-surge

Tech Stocks Set To Rise Thursday As Januar...
02/29/2024 14:20:35

Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&P 5...

Why Okta Shares Are Trading Higher By Arou...
02/29/2024 13:04:20

Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-e...

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
02/28/2024 21:31:07

Voyager Therapeutics: Q4 Earnings Insights
02/28/2024 21:30:35

Voyager Therapeutics Q4 2023 GAAP EPS $1.2...
02/28/2024 21:27:48

Voyager Therapeutics (NASDAQ:VYGR) reported quarterly earnings of $1.25 per share which beat the analyst consensus estimate of ...

Earnings Scheduled For February 28, 2024
02/28/2024 11:24:02

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

Earnings Preview For Voyager Therapeutics
02/27/2024 18:01:10

Selection Of The Development Candidate For...
02/26/2024 12:14:19

Voyager Is Eligible To Receive Additional Future Development And Commercialization Milestone Payments Based On The Further Adva...

Voyager Therapeutics Announced That The Jo...
02/26/2024 12:12:50

The candidate combines a frataxin (FXN) gene replacement payload with an intravenously administered, blood-brain barrier penetr...

Voyager Therapeutics Reports Preclinical A...
02/20/2024 12:09:26

Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announce...